Inhibition of Ca2+-activated Cl- channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma

Cancer Letters

Volumn 326, Issue 1, 2012, Pages 41-51

  Liu, Wen ^a   Lu, Min ^a   Liu, Baogang ^b   Huang, Yi ^c   Wang, KeWei ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

ANO1; Metastasis; PC 3 cells; Proliferation; Prostate cancer

Indexed keywords

ANOCTAMIN 1; CALCIUM ACTIVATED CHLORIDE CHANNEL; CHLORIDE CHANNEL; MESSENGER RNA; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOCTAMIN 1 GENE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN LNCAP; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATCH CLAMP; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; CHLORIDE CHANNELS; DISEASE PROGRESSION; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; UP-REGULATION;

MUS MUSCULUS;

EID: 84866143707     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.07.015     Document Type: Article

References (43)

1. Edwards S.M., Evans D.G.R., Hope Q., Norman A.R., Barbachano Y., Bullock S., Kote-Jarai Z., Meitz J., Falconer A., Osin P., Fisher C., Guy M., Jhavar S.G., Hall A.L., O'Brien L.T., Gehr-Swain B.N., Wilkinson R.A., Forrest M.S., Dearnaley D.P., Ardern-Jones A.T., Page E.C., Easton D.F., Eeles R.A., Study U.G.P.C. Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis. Br. J. Cancer 2010, 103:918-924.
2. Diss J.K., Stewart D., Pani F., Foster C.S., Walker M.M., Patel A., Djamgoz M.B. A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic. Dis. 2005, 8:266-273.
3. Fraser S.P., Diss J.K., Chioni A.M., Mycielska M.E., Pan H., Yamaci R.F., Pani F., Siwy Z., Krasowska M., Grzywna Z., Brackenbury W.J., Theodorou D., Koyuturk M., Kaya H., Battaloglu E., De Bella M.T., Slade M.J., Tolhurst R., Palmieri C., Jiang J., Latchman D.S., Coombes R.C., Djamgoz M.B. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin. Cancer Res. 2005, 11:5381-5389.
4. Parekh A.B., Putney J.W. Store-operated calcium channels. Physiol. Rev. 2005, 85:757-810.
5. B. Hille (Ed.), Ion Channels of Excitable Membranes, Sinauer, third ed., 2001.
6. Lang F., Foller M., Lang K.S., Lang P.A., Ritter M., Gulbins E., Vereninov A., Huber S.M. Ion channels in cell proliferation and apoptotic cell death. J. Membr. Biol. 2005, 205:147-157.
7. Razik M.A., Cidlowski J.A. Molecular interplay between ion channels and the regulation of apoptosis. Biol. Res. 2002, 35:203-207.
8. Haussinger D. The role of cellular hydration in the regulation of cell function. Biochem. J. 1996, 313(Pt 3):697-710.
9. Lang F., Busch G.L., Ritter M., Volkl H., Waldegger S., Gulbins E., Haussinger D. Functional significance of cell volume regulatory mechanisms. Physiol. Rev. 1998, 78:247-306.
10. Furst J., Gschwentner M., Ritter M., Botta G., Jakab M., Mayer M., Garavaglia L., Bazzini C., Rodighiero S., Meyer G., Eichmuller S., Woll E., Paulmichl M. Molecular and functional aspects of anionic channels activated during regulatory volume decrease in mammalian cells. Pflugers Arch. 2002, 444:1-25.
11. Okada Y., Shimizu T., Maeno E., Tanabe S., Wang X., Takahashi N. Volume-sensitive chloride channels involved in apoptotic volume decrease and cell death. J. Membr. Biol. 2006, 209:21-29.
12. -) channel activity. J. Biol. Chem. 2002, 277:15592-15599.
13. Shuba Y.M., Prevarskaya N., Lemonnier L., Van Coppenolle F., Kostyuk P.G., Mauroy B., Skryma R. Volume-regulated chloride conductance in the LNCaP human prostate cancer cell line. Am. J. Physiol. Cell Physiol. 2000, 279:C1144-C1154.
14. 2+ modulation of volume-regulated anion channels: evidence for colocalization with store-operated channels. FASEB J. 2002, 16:222-224.
15. 2+ transporter type 1. J. Biol. Chem. 2003, 278:15381-15389.
16. Hartzell C., Putzier I., Arreola J. Calcium-activated chloride channels. Annu. Rev. Physiol. 2005, 67:719-758.
17. Duran C., Thompson C.H., Xiao Q., Hartzell H.C., enigmatic Chloride channels: often rarely predictable. Annu. Rev. Physiol. 2010, 72:95-121.
18. Caputo A., Caci E., Ferrera L., Pedemonte N., Barsanti C., Sondo E., Pfeffer U., Ravazzolo R., Zegarra-Moran O., Galietta L.J. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 2008, 322:590-594.
19. Yang Y.D., Cho H., Koo J.Y., Tak M.H., Cho Y., Shim W.S., Park S.P., Lee J., Lee B., Kim B.M., Raouf R., Shin Y.K., Oh U. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 2008, 455:1210-1215.
20. Schroeder B.C., Cheng T., Jan Y.N., Jan L.Y. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell 2008, 134:1019-1029.
21. Katoh M. FLJ10261 gene, located within the CCND1-EMS1 locus on human chromosome 11q13, encodes the 8-transmembrane protein homologous to C12orf3, C11orf25 and FLJ34272 gene products. Int. J. Oncol. 2003, 22:1375-1381.
22. Schwab M. Amplification of oncogenes in human cancer cells. Bioessays 1998, 20:473-479.
23. Akervall J.A., Jin Y., Wennerberg J.P., Zatterstrom U.K., Kjellen E., Mertens F., Willen R., Mandahl N., Heim S., Mitelman F. Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer 1995, 76:853-859.
24. Huang X., Godfrey T.E., Gooding W.E., McCarty K.S., Gollin S.M. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosom. Cancer 2006, 45:1058-1069.
25. West R.B., Corless C.L., Chen X., Rubin B.P., Subramanian S., Montgomery K., Zhu S., Ball C.A., Nielsen T.O., Patel R., Goldblum J.R., Brown P.O., Heinrich M.C., Van de Rijn M. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am. J. Pathol. 2004, 165:107-113.
26. Chen Z., Gu J. Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J. 2007, 21:2931-2938.
27. Kanemura Y., Mori H., Kobayashi S., Islam O., Kodama E., Yamamoto A., Nakanishi Y., Arita N., Yamasaki M., Kano H., Hara M., Miyake J. Evaluation of in vitro proliferative activity of human fetal neural stem/progenitor cells using indirect measurements of viable cells based on cellular metabolic activity. J. Neurosci. Res. 2002, 69:869-879.
28. Zeng X., Sikka S.C., Huang L., Sun C., Xu C., Jia D., Abdel-Mageed A.B., Pottle J.E., Taylor J.T., Li M. Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation. Prostate Cancer Prostatic Dis 2010, 13:195-201.
29. Shao L., Cui Y., Li H.Y., Liu Y., Zhao H.S., Wang Y., Zhang Y.M., Ng K.M., Han W.L., Ma D.L., Ta Q. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Clin. Cancer Res. 2007, 13:5756-5762.
30. Wang Y., Zhang H., Chen Y.P., Sun Y.M., Yang F., Yu W.H., Liang J., Sun L.Y., Yang X.H., Shi L., Li R.F., Li Y.Y., Zhang Y., Li Q., Yi X., Shang Y.F. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 2009, 138:660-672.
31. Lee P.C., Kakadiya R., Su T.L., Lee T.C. Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells. Neoplasia 2010, 12:U372-U376.
32. Pulukuri S.M., Gondi C.S., Lakka S.S., Jutla A., Estes N., Gujrati M., Rao J.S. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. J. Biol. Chem. 2005, 280:36529-36540.
33. Chlenski A., Nakashiro K., Ketels K.V., Korovaitseva G.I., Oyasu R. Androgen receptor expression in androgen-independent prostate cancer cell lines. Prostate 2001, 47:66-75.
34. van Bokhoven A., Varella-Garcia M., Korch C., Johannes W.U., Smith E.E., Miller H.L., Nordeen S.K., Miller G.J., Lucia M.S. Molecular characterization of human prostate carcinoma cell lines. Prostate 2003, 57:205-225.
35. Alimirah F., Chen J., Basrawala Z., Xin H., Choubey D. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett. 2006, 580:2294-2300.
36. Stone K.R., Mickey D.D., Wunderli H., Mickey G.H., Paulson D.F. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer. 1978, 21:274-281.
37. Ayoub C., Wasylyk C., Li Y., Thomas E., Marisa L., Robe A., Roux M., Abecassis J., de Reynies A., Wasylyk B. ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines. Br. J. Cancer 2010, 103:715-726.
38. 2+-activated anion currents in Ehrlich lettre ascites cells. J. Cell Physiol. 2007, 210:831-842.
39. Kunzelmann K. Ion channels and cancer. J. Membr. Biol. 2005, 205:159-173.
40. Tapia-Vieyra J.V., Mas-Oliva J. Apoptosis and cell death channels in prostate cancer. Arch. Med. Res. 2001, 32:175-185.
41. Catz S.D., Johnson J.L. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 2001, 20:7342-7351.
42. Prevarskaya N., Skryma R., Bidaux G., Flourakis M., Shuba Y. Ion channels in death and differentiation of prostate cancer cells. Cell Death Differ. 2007, 14:1295-1304.
43. 2+ store to the plasma membrane. Nature 2005, 437:902-905.